| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 05:10 | Aufgepasst! Riesiges Marktpotenzial im größten Teilbereich der Pharmabranche nutzen: mit Innovator Vidac Pharma, Platzhirsch Bayer oder Turnaround-Kandidat Evotec? | 1.267 | inv3st.de | Die Onkologie ist der strategisch wichtigste Wachstumsmarkt der Pharmaindustrie und gleichzeitig einer der entscheidenden Hebel zur Verbesserung der globalen Gesundheit. Aktuell erkranken weltweit rund... ► Artikel lesen | |
| Do | Vanda Pharmaceuticals Inc.: Vanda Pharmaceuticals Calls on FDA to Withdraw Proposal from FY 2027 Legislative Agenda That Would Extend Drug Review Timelines | 748 | PR Newswire | WASHINGTON, April 9, 2026 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA) today highlighted a legislative proposal contained in the FDA's FY 2027... ► Artikel lesen | |
| Do | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 09.04.2026 | 623 | Xetra Newsboard | The following instruments on Boerse Frankfurt do have their last trading day on 09.04.2026Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 09.04.2026ISIN NameCA29286M1059 ENGENE... ► Artikel lesen | |
| Do | Strategische Weichenstellung im Exosomenmarkt | Small- & Micro Cap Investment | |||
| 11:57 | EQS-PVR: Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution | 345 | EQS Group (EN) | EQS Voting Rights Announcement: Evotec SE
Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide... ► Artikel lesen | |
| 11:51 | EQS-PVR: Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution | 344 | EQS Group (EN) | EQS Voting Rights Announcement: Evotec SE
Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide... ► Artikel lesen | |
| Do | Tempus AI Expands Collaboration With Gilead Sciences To Maximize Insights In Oncology Pipeline | 325 | AFX News | FOSTER CITY (dpa-AFX) - Healthcare technology company Tempus AI, Inc. (TEM) Thursday announced an expanded, multi-year collaboration with Gilead Sciences, Inc. (GILD) to build and advance its... ► Artikel lesen | |
| 07:10 | Idorsia Pharmaceuticals Ltd: Idorsia issues invitation to the 2026 Annual General Meeting of Shareholders | 306 | GlobeNewswire (Europe) | Allschwil, Switzerland - April 10, 2026Idorsia Ltd (SIX: IDIA) today issued the invitation to the upcoming Annual General Meeting (AGM) of Shareholders on behalf of the Board of Directors. The meeting... ► Artikel lesen | |
| Do | iSpecimen Inc.: iSpecimen Achieves 85% Reduction in Human Biospecimen Shipping Time | 259 | Newsfile | Woburn, Massachusetts--(Newsfile Corp. - April 9, 2026) - iSpecimen (NASDAQ: ISPC), an online marketplace for human biospecimens, has implemented a streamlined shipping model that enables direct... ► Artikel lesen | |
| Do | Bullion Gold Resources Corporation: Bullion Gold Completes Drilling Program on Langlade Project | 236 | Newsfile | Montreal, Quebec--(Newsfile Corp. - April 9, 2026) - Bullion Gold Resources Corp. (TSXV: BGD) ("Bullion Gold" or the "Company") is pleased to announce that it has successfully completed its diamond... ► Artikel lesen | |
| Do | OSR Holdings, Inc.: OSR Holdings Eliminates $2.02 Million Warrant Overhang with Premium-Priced Convertible Note | 216 | ACCESS Newswire | BELLEVUE, WA / ACCESS Newswire / April 9, 2026 / OSR Holdings, Inc. (NASDAQ:OSRH) ("OSR Holdings" or the "Company") today announced a strategic transaction for capital structure optimization with White... ► Artikel lesen | |
| Do | XFRA ISIN CHANGE | 194 | Xetra Newsboard | Einstellung Aufnahme ISIN Name Einstellung mit Ablauf: ISIN Name Ab dem: AnmerkungenCA29286M1059 enGene Therapeutics Inc. 09.04.2026 CA29286X1015 enGene Therapeutics Inc. 10.04.2026 Tausch 1:1US78396V2088 SCWorx... ► Artikel lesen | |
| 09:30 | Biosergen AB receives observation status | 151 | GlobeNewswire | On April 4, 2026, Biosergen AB ("the Company") disclosed that the Company's board of directors had resolved to pause the development of BSG005 and that the board of directors is exploring the possibility... ► Artikel lesen | |
| 09:00 | The observation status for Guard Therapeutics International AB (publ) is updated | 132 | GlobeNewswire | On December 11, 2025, the shares in Guard Therapeutics International AB (publ) (the "Company") were given observation status with reference to information that the Company's board of directors had... ► Artikel lesen | |
| Do | Faron Pharmaceuticals Oy: Faron publishes final results of its EUR 40.1 million rights issue | 103 | GlobeNewswire (Europe) | Faron Pharmaceuticals Ltd | Company announcement | April 09, 2026 at 20:25:00 EEST
Faron publishes final results of its EUR 40.1 million rights issue
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY... ► Artikel lesen |
| Unternehmen / Aktien | Kurs | Dividende 12M | Div.-Rendite | Erw. Dividende | Erw. Ex.-Datum | |
|---|---|---|---|---|---|---|
| BB BIOTECH | 48,950 | 2,47 | +5,05 % | 2,25 | 23.03.2026 | |
| CSL | 83,73 | 2,61 | +3,12 % | 1,84 | 10.03.2026 | |
| AMGEN | 302,20 | 8,25 | +2,73 % | 2,52 | 15.05.2026 | |
| RECORDATI | 48,960 | 1,30 | +2,66 % | 0,71 | 18.05.2026 | |
| NOVONESIS | 51,26 | 0,87 | +1,70 % | 4,25 | 20.03.2026 | |
| SINO BIOPHARM | 0,634 | 0,01 | +1,58 % | 0,05 | 24.06.2026 | |
| GENUS | 29,400 | 0,38 | +1,29 % | 0,11 | 05.03.2026 | |
| 3SBIO | 2,430 | 0,03 | +1,23 % | 0,25 | 21.07.2026 | |
| VITROLIFE | 9,110 | 0,10 | +1,10 % | 1,10 | 06.05.2026 | |
| BIOMERIEUX | 89,35 | 0,90 | +1,01 % | 0,98 | 09.06.2026 |